<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78277</article-id><article-id pub-id-type="doi">10.7554/eLife.78277</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Targeted depletion of uterine glandular Foxa2 induces embryonic diapause in mice</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-272541"><name><surname>Matsuo</surname><given-names>Mitsunori</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-287031"><name><surname>Yuan</surname><given-names>Jia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4807-8646</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="pa2">§</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-202343"><name><surname>Kim</surname><given-names>Yeon Sun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4854-8334</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-187338"><name><surname>Dewar</surname><given-names>Amanda</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-272542"><name><surname>Fujita</surname><given-names>Hidetoshi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-21212"><name><surname>Dey</surname><given-names>Sudhansu K</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9159-186X</contrib-id><email>sk.dey@cchmc.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-43457"><name><surname>Sun</surname><given-names>Xiaofei</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9601-5423</contrib-id><email>xiaofei.sun@cchmc.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01hcyya48</institution-id><institution>Division of Reproductive Sciences, Cincinnati Children’s Hospital Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01e3m7079</institution-id><institution>College of Medicine, University of Cincinnati</institution></institution-wrap><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02znffm54</institution-id><institution>Department of Biomedical Engineering, Osaka Institute of Technology</institution></institution-wrap><addr-line><named-content content-type="city">Osaka</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yan</surname><given-names>Wei</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dxps055</institution-id><institution>California Institute of Technology</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="present-address" id="pa1"><label>‡</label><p>Department of Obstetrics and Gynecology, University of Tokyo, Tokyo, Japan</p></fn><fn fn-type="present-address" id="pa2"><label>§</label><p>The Second Hospital and Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>21</day><month>07</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e78277</elocation-id><history><date date-type="received" iso-8601-date="2022-02-28"><day>28</day><month>02</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-07-20"><day>20</day><month>07</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-03-17"><day>17</day><month>03</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.03.15.484401"/></event></pub-history><permissions><copyright-statement>© 2022, Matsuo, Yuan, Kim et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Matsuo, Yuan, Kim et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78277-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-78277-figures-v2.pdf"/><abstract><p>Embryonic diapause is a reproductive strategy in which embryo development and growth is temporarily arrested within the uterus to ensure the survival of neonates and mothers during unfavorable conditions. Pregnancy is reinitiated when conditions become favorable for neonatal survival. The mechanism of how the uterus enters diapause in various species remains unclear. Mice with uterine depletion of <italic>Foxa2,</italic> a transcription factor, are infertile. In this study, we show that dormant blastocysts are recovered from these mice on day 8 of pregnancy with persistent expression of uterine <italic>Msx1</italic>, a gene critical to maintaining the uterine quiescent state, suggesting that these mice enter embryonic diapause. Leukemia inhibitory factor (LIF) can resume implantation in these mice. Although estrogen is critical for implantation in progesterone-primed uterus, our current model reveals that FOXA2-independent estrogenic effects are detrimental to sustaining uterine quiescence. Interestingly, progesterone and anti-estrogen can prolong uterine quiescence in the absence of FOXA2. Although we find that <italic>Msx1</italic> expression persists in the uterus deficient in <italic>Foxa2,</italic> the complex relationship of FOXA2 with <italic>Msx</italic> genes and estrogen receptors remains to be explored.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>diapause</kwd><kwd>Foxa2</kwd><kwd>dormant</kwd><kwd>delayed pregnancy</kwd><kwd>uterus</kwd><kwd>estrogen</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>HD103475</award-id><principal-award-recipient><name><surname>Dey</surname><given-names>Sudhansu K</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>HD068524</award-id><principal-award-recipient><name><surname>Dey</surname><given-names>Sudhansu K</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF-2021R1A6A3A03038446</award-id><principal-award-recipient><name><surname>Kim</surname><given-names>Yeon Sun</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Leukemia inhibitory factor (LIF) suppression is not sufficient to maintain long-term uterine quiescence like in ovariectomized mice maintained on progesterone supplement, and estrogen has an adverse impact on uterine quiescence independent of FOXA2 (forkhead box protein A2)/LIF.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Embryonic diapause is a reproductive strategy in which embryo development and growth is temporarily arrested within the uterus, but is reinitiated when conditions are favorable for neonatal and maternal survival (<xref ref-type="bibr" rid="bib3">Cha and Dey, 2014</xref>; <xref ref-type="bibr" rid="bib10">Fenelon and Renfree, 2018</xref>). During diapause, blastocyst growth, DNA synthesis, mitosis, and metabolic activity are temporarily downregulated in the uterus to achieve a quiescent state to support blastocyst survival.</p><p>The triggers for diapause vary widely across species, ranging from photoperiod, temperature, metabolic stress, lactation, or nutrition (<xref ref-type="bibr" rid="bib17">Lopes et al., 2004</xref>). It is known to occur in more than 100 species spanning over seven orders. In mice, experimental ovariectomy early on the morning of day 4, before preimplantation estrogen (E<sub>2</sub>) secretion, induces embryonic diapause (<xref ref-type="bibr" rid="bib36">Yoshinaga and Adams, 1966</xref>); alternatively, embryonic diapause can be induced by injections of estrogen receptor (ER) antagonists on days 3 and 4 of pregnancy to neutralize E<sub>2</sub> function (<xref ref-type="bibr" rid="bib2">Cha et al., 2013</xref>). Blastocyst reactivation can be rapidly initiated by a single injection of E<sub>2</sub> in an ovariectomized dormant uterus (<xref ref-type="bibr" rid="bib36">Yoshinaga and Adams, 1966</xref>). Preimplantation E<sub>2</sub> secretion on day 4 morning induces leukemia inhibitory factor (LIF) to initiate implantation. Interestingly, blastocysts in <italic>Lif<sup>-/-</sup></italic> females undergo diapause (<xref ref-type="bibr" rid="bib27">Stewart et al., 1992</xref>). In spite of these recognized factors, the molecular mechanism which initiates embryonic diapause is still not fully understood.</p><p>FOXA2 (forkhead box protein A2), which is expressed in glandular epithelia in the mouse uterus, plays a key role in uterine gland development and implantation. Neonatal depletion of uterine <italic>Foxa2</italic> causes a significant reduction in the number of glands (<xref ref-type="bibr" rid="bib12">Jeong et al., 2010</xref>). Female mice with uterine glandular depletion of <italic>Foxa2</italic> after puberty have implantation/decidualization failure due to compromised LIF induction on day 4 of pregnancy (<xref ref-type="bibr" rid="bib14">Kelleher et al., 2017</xref>).</p><p>In this study, we show that depletion of <italic>Foxa2</italic> in mouse uterine glands causes embryonic diapause. Dormant embryos were retrieved from uteri on day 8 of pregnancy. <italic>Msx1</italic> expression, which appears to be critical to maintain a quiescent uterine environment (<xref ref-type="bibr" rid="bib2">Cha et al., 2013</xref>), was maintained in <italic>Foxa2</italic> deficient mice in our studies. Although implantation was triggered by a single LIF injection on day 8 of pregnancy in <italic>Foxa2</italic> deficient mice, these mice are not able to support pregnancy to full term. Furthermore, we found that balancing of estrogenic effects by either progesterone (P<sub>4</sub>) supplement or application of an ER antagonist significantly improves survival of embryos in <italic>Foxa2</italic> deficient mice. Our study reveals that <italic>Foxa2</italic> plays an important role in mammalian embryonic diapause and that FOXA2-independent E<sub>2</sub> effects are detrimental to uterine quiescence during diapause.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Uterine depletion of Foxa2 results in female infertility due to disrupted Lif induction during implantation</title><p>Previous reports have shown that <italic>Foxa2</italic> is expressed in the glandular epithelium before and during pregnancy (<xref ref-type="bibr" rid="bib12">Jeong et al., 2010</xref>; <xref ref-type="bibr" rid="bib33">Wang et al., 2018</xref>). Uterine glandular <italic>Foxa2</italic> is critical to normal implantation (<xref ref-type="bibr" rid="bib14">Kelleher et al., 2017</xref>). Using mice with uterine-specific (<italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic>) and uterine epithelial-specific depletion of <italic>Foxa2</italic> (<italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic>), we confirmed that these mice are infertile (<xref ref-type="fig" rid="fig1">Figure 1a</xref>) due to the lack of <italic>Lif</italic> induction on day 4 of pregnancy (<xref ref-type="fig" rid="fig1">Figure 1d</xref>). Since the timing and domain of Cre activity driven by an <italic>Ltf</italic> or <italic>Pgr</italic> promoter differs (<xref ref-type="fig" rid="fig1">Figure 1b</xref>), <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> females maintain FOXA2 expression in uterine glands before puberty (<xref ref-type="fig" rid="fig1">Figure 1c</xref>), whereas <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females have a minimal number of glands on postnatal day 30 (<xref ref-type="fig" rid="fig1">Figure 1c</xref>) due to early depletion of <italic>Foxa2</italic> (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). In mature pregnant females, no positive signals of FOXA2 are observed in either of the two mouse models on day 4 of pregnancy (<xref ref-type="fig" rid="fig1">Figure 1c</xref>). The efficient depletion of <italic>Foxa2</italic> RNA in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic>uteri is confirmed by quantitative PCR (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Uterine conditional depletion of <italic>Foxa2</italic> causes loss of leukemia inhibitory factor (LIF) secretion and female infertility.</title><p>(<bold>a</bold>) Percentage of mice with pups per total mated mice.Numbers on bars indicate mice with pups over total number of mated mice. *p &lt; 0.05 by Student's t-test. (<bold>b</bold>) Cre recombinase activity starts differently in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> females. (<bold>c</bold>) Immunostaining of FOXA2 in the uteri on postnatal day 30 and day 4 pregnancy of <italic>Foxa2<sup>f/f</sup></italic>, <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup>,</italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>females. Epithelial cells are outlined by cytokeratin 8 (CK8) staining. Scale bars: 100 μm. (<bold>d</bold>) In situ hybridization of <italic>Lif</italic> in day 4 of pregnant uteri from <italic>Foxa2<sup>f/f</sup></italic>, <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup>,</italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> females. White arrows point to uterine glands. Scale bar: 200 μm. Le, luminal epithelia; Ge, glandular epithelia; S, stroma.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78277-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Quantitative PCR of <italic>Foxa2</italic> in <italic>Foxa2<sup>f/f</sup></italic>, <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup>,</italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>uteri tissues on day 4 of pregnancy.</title><p>RNA levels of <italic>Foxa2</italic> are normalized against <italic>Rpl7</italic>. Values are mean ± SEM; *p &lt; 0.05 by Student's t-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78277-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Blastocysts enter embryonic diapause in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+ </sup></italic>mice</title><p>Suppression of preimplantation E<sub>2</sub> secretion on day 4 of pregnancy renders mouse uteri quiescent to implantation. This uterine status can be extended by a daily supplement of P<sub>4</sub>. Unimplanted blastocyst development in quiescent uteri is arrested (<xref ref-type="bibr" rid="bib22">Renfree and Shaw, 2000</xref>; <xref ref-type="bibr" rid="bib9">Fenelon et al., 2014</xref>; <xref ref-type="bibr" rid="bib24">Sherman and Barlow, 1972</xref>) in <italic>Lif<sup>-/-</sup></italic> females, blastocysts recovered on day 7 of pregnancy retained implantation capabilities once transferred to wild-type surrogate uteri (<xref ref-type="bibr" rid="bib27">Stewart et al., 1992</xref>). This result suggests that <italic>Lif<sup>-/-</sup></italic> uteri are able to maintain the quiescent phase in spite of presumed E<sub>2</sub> secretion on day 4 of pregnancy. Given the absence of LIF induction in <italic>Foxa2</italic> deficient uteri, we next examined whether <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uteri enter diapause after day 4 of pregnancy.</p><p>Day 8 uteri were examined for implantation in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic>, <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup>,</italic> and control (<italic>Foxa2<sup>f/f</sup></italic>) females. <italic>Foxa2<sup>f/f</sup></italic> uteri show implantation sites with apparently normal morphology (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). In contrast, the numbers of implantation sites were significantly lower in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> or <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females as compared to <italic>Foxa2<sup>f/f</sup></italic> females (<xref ref-type="fig" rid="fig2">Figure 2a</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, Table 1). The frequency of mated females with implantation sites in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> mice was 16.7% (1/6) and 42.9% (3/7), respectively, significantly lower than those in <italic>Foxa2<sup>f/f</sup></italic> mice (100%, 6/6) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, Table 1).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Dormant blastocysts are present in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>uteri on day 8 pregnancy.</title><p>(<bold>a</bold>) Representative photographs of day 8 pregnant uteri from <italic>Foxa2<sup>f/f</sup></italic>, <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup>,</italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> females. An ovariectomy-induced delayed model of <italic>Foxa2<sup>f/f</sup></italic> mice served as a prototypical control in maintaining dormant blastocysts. Scale bar: 10 mm. Ov, ovary. (<bold>b</bold>) Blastocysts recovered from <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>uteri on day 8. Blastocysts retrieved from ovariectomized <italic>Foxa2<sup>f/f</sup></italic> mice in delay served as controls. ICM, inner cell mass. Scale bar: 100 µm. Quantification of blastocyst numbers were shown in panel <bold>c</bold>. Numbers on bars indicate numbers of animals examined. Values are expressed as mean + SEM. (<bold>d</bold>) Representative photographs of nuclear staining of dormant blastocysts recovered from mice without implantation sites. Scale bar: 50 µm. (<bold>e</bold>) Average cell numbers per blastocyst. Numbers of embryos examined are shown on bars. Values are expressed as mean + SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78277-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>A schematic outline of sample collection from ovariectomy-induced delayed model.</title><p>P<sub>4</sub>, progesterone (2 mg) administration.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78277-fig2-figsupp1-v2.tif"/></fig></fig-group><p>Dormant blastocysts were recovered by flushing <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uterine horns on day 8 of pregnancy (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). A diapause model created by ovariectomy on day 4 of pregnancy was used as a prototypical control (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), in which ~4.5 dormant blastocysts were retrieved. A similar number of blastocysts was recovered from <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uterine horns on day 8 of pregnancy (<xref ref-type="fig" rid="fig2">Figure 2c</xref>), and they morphologically resembled the dormant blastocysts from the ovariectomy delayed model (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). It is known that dormant blastocysts cease mitotic activity and cell proliferation (<xref ref-type="bibr" rid="bib2">Cha et al., 2013</xref>). Using DAPI staining (<xref ref-type="fig" rid="fig2">Figure 2d</xref>), we found that blastocysts retrieved from <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uteri have comparable cell numbers to those recovered from diapausing uteri achieved by ovariectomy (<xref ref-type="fig" rid="fig2">Figure 2e</xref>).</p></sec><sec id="s2-3"><title><italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+ </sup></italic>uteri show characteristics of uterine quiescence</title><p>Uterine quiescence apparently depends on the presence of muscle segment homeobox (<italic>Msx</italic>) genes. In mice and other diapausing animals, such as in mink and Tamar Wallaby, <italic>Msx1</italic> and <italic>Msx2</italic> genes persist during diapause, but their levels are quickly suppressed with blastocyst reactivation and implantation (<xref ref-type="bibr" rid="bib2">Cha et al., 2013</xref>). However, mice with uterine conditional depletion of both <italic>Msx1</italic> and <italic>Msx2</italic> fail to achieve diapause and reactivation (<xref ref-type="bibr" rid="bib2">Cha et al., 2013</xref>; <xref ref-type="bibr" rid="bib4">Cha et al., 2020</xref>). Since dormant blastocysts were recovered from <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uteri on day 8 of pregnancy, we suspected that <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uteri remain quiescent in the absence of LIF induction. We examined <italic>Msx1</italic> expression in the uterus on days 4 and 8 of pregnancy by fluorescence in situ hybridization. <italic>Msx1</italic> signals were observed in epithelial cells before the E<sub>2</sub> surge on day 4 in <italic>Foxa2<sup>f/f</sup></italic> uteri, whereas luminal epithelial <italic>Msx1</italic> signals were suppressed after the E<sub>2</sub> secretion (<xref ref-type="fig" rid="fig3">Figure 3a</xref>; <xref ref-type="bibr" rid="bib6">Daikoku et al., 2011</xref>). Remarkably, <italic>Msx1</italic> expression persisted in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> luminal epithelial cells on day 8 of pregnancy (<xref ref-type="fig" rid="fig3">Figure 3a</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> females maintain uterine quiescence when examined on day 8 of pregnancy.</title><p>(<bold>a</bold>) Fluorescence in situ hybridization of <italic>Msx1</italic> in days 4 and 8 pregnant uteri from <italic>Foxa2<sup>f/f</sup></italic>, <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup>,</italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> females. Scale bar: 200 μm. (<bold>b</bold>) Epidermal growth factor receptor (EGFR) immunostaining on dormant blastocysts. Positive signals were observed in activated blastocysts recovered from <italic>Foxa2<sup>f/f</sup></italic> uteri on day 4 of pregnancy. Scale bar: 25 μm. (<bold>c</bold>) Ki67 immunostaining on dormant blastocysts collected from day 8 <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> females. Scale bar: 25 μm. ICM, inner cell mass.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78277-fig3-v2.tif"/></fig><p>Epidermal growth factor receptor (EGFR) is present in day 4 blastocysts, but becomes suppressed during dormancy (<xref ref-type="bibr" rid="bib19">Paria et al., 1993a</xref>). This is consistent with our current findings that EGFR expression is significantly lower in blastocysts recovered from <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uteri on day 8 of pregnancy as compared to those retrieved from <italic>Foxa2<sup>f/f</sup></italic> uteri in the evening of day 4 (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). The mitotic activity (Ki67 staining) in the trophectoderm of the recovered blastocysts in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> mice on day 8 is also arrested (<xref ref-type="fig" rid="fig3">Figure 3c</xref>). This result is consistent with a study by Fujimori’s group (<xref ref-type="bibr" rid="bib13">Kamemizu and Fujimori, 2019</xref>). Collectively, the results suggest that <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uteri remain quiescent until at least day 8 of pregnancy, providing a uterine environment suitable for embryonic diapause.</p></sec><sec id="s2-4"><title>Uterine activation in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> mice deteriorates during diapause</title><p>Embryonic diapause and uterine quiescence are reversible with a single injection of E<sub>2</sub> or LIF in mice (<xref ref-type="bibr" rid="bib36">Yoshinaga and Adams, 1966</xref>; <xref ref-type="bibr" rid="bib5">Chen et al., 2000</xref>). Implantation failure has been shown to be rescued in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females by LIF administration on day 4 (<xref ref-type="bibr" rid="bib14">Kelleher et al., 2017</xref>). No further analysis was carried out. Since dormant blastocysts are recovered from <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uteri on day 8 of pregnancy in our studies, we examined if the diapausing blastocysts can be rejuvenated. <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females received one injection of recombinant LIF (20 μg/mouse) on day 4 or 8, and the uteri were examined 2 days later (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). Consistent with the previous report (<xref ref-type="bibr" rid="bib14">Kelleher et al., 2017</xref>), implantation sites were observed in both <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uteri if LIF was given on day 4 of pregnancy (<xref ref-type="fig" rid="fig4">Figure 4b</xref>). Further histological evaluations reveal that normal-looking implantation chambers formed similar to those in <italic>Foxa2<sup>f/f</sup></italic>mice on day 6 of pregnancy (<xref ref-type="fig" rid="fig4">Figure 4b and c</xref>). Almost all <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> females (five of six) possessed implantation sites, whereas less than half (four of nine) <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females had implantation sites (<xref ref-type="fig" rid="fig4">Figure 4d</xref>), although the number of implantation sites was comparable in pregnant females.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Pregnancy in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> females with leukemia inhibitory factor (LIF) treatment.</title><p>(<bold>a</bold>) Schematic outline of sample collection. LIF, LIF administration (20 μg). (<bold>b</bold>) Representative photograph of uteri from <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> females (days 6 and 10) with LIF treatment. <italic>Foxa2<sup>f/f</sup></italic> uteri on day 6 serve as control. Scale bar: 10 mm. Histological pictures of implantation sites in panel b were presented in panel <bold>c</bold>. Arrowheads point to embryos. Em, embryo. Scale bar: 500 μm. (<bold>d</bold>) Average number of implantation sites in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> mice treated with LIF (20 μg) on day 4 or 8 of pregnancy. Numbers and percentage on bars indicate mice with implantation sites over total number of mated mice. (<bold>e</bold>) Litter sizes of <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>mice treated with LIF (20 μg) or vehicle on days 4 or 8 of pregnancy. Numbers and percentage on bars indicate mice with pups over total number of mated mice. *p&lt;0.05. (<bold>f</bold>) 3D visualization of day 6 implantation sites in <italic>Foxa2<sup>f/f</sup></italic>, <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup>,</italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>females. Images of E-cadherin immunostaining, segmented, and 3D rendered images of day 6 implantation sites in each genotype show defects in <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> females with a LIF injection on day 4 of pregnancy. Scale bar: 200 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78277-fig4-v2.tif"/></fig><p>Notably, implantation sites with a normal appearance were observed in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> uteri when LIF was given on day 8 of pregnancy (<xref ref-type="fig" rid="fig4">Figure 4b</xref>), albeit edematous uteri in <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> with faint blue bands. Histology of implantation sites confirmed this observation. Implantation chambers form in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> implantation sites, but neither embryos nor implantation chambers were found in <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> implantation sites (<xref ref-type="fig" rid="fig4">Figure 4c</xref>). The rate of <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> females with implantation sites decreased from 83.3% to 50% in females receiving LIF injection on day 4 (<xref ref-type="fig" rid="fig4">Figure 4d</xref>). All <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females showed abnormal light blue bands without recognizable implantation chambers when examined 2 days after LIF injection, and the implantation chambers showed no further development (<xref ref-type="fig" rid="fig4">Figure 4d</xref>).</p><p>Glands have been shown to be essential for implantation and pregnancy success (<xref ref-type="bibr" rid="bib14">Kelleher et al., 2017</xref>; <xref ref-type="bibr" rid="bib11">Gray et al., 2001</xref>). FOXA2 plays a key role in mouse uterine glandular genesis, and neonatal depletion of <italic>Foxa2</italic> in mouse uteri causes defects in gland development (<xref ref-type="bibr" rid="bib12">Jeong et al., 2010</xref>). To examine glands, day 6 implantation sites of <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females with LIF injection on day 4 were stained with an E-cadherin antibody. Tridimensional images were acquired as previously described (<xref ref-type="bibr" rid="bib37">Yuan et al., 2018</xref>). The number of glands in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> implantation sites was significantly reduced compared to those in natural day 6 implantation sites of <italic>Foxa2<sup>f/f</sup></italic> females (<xref ref-type="fig" rid="fig4">Figure 4f</xref>). As previously reported (<xref ref-type="bibr" rid="bib12">Jeong et al., 2010</xref>), glands were rarely observed in <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> implantation sites. These data suggest that an increased number of glands is not required for uterine quiescence and embryonic diapause, but the presence of a minimal number of glands is critical for reactivation after diapause.</p><p>In mammalian embryonic diapause, arrest of blastocyst development and uterine quiescence are transitory. Upon reactivation, the uterine environment becomes competent to support embryo development to term when conditions are favorable for neonatal survival. To study whether reactivated uteri in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females are able to support full-term pregnancy, litter sizes were counted. Six of eight <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic>, but only 4 of 15 <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females injected with LIF on day 4 successfully delivered live pups, and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females have reduced litter sizes (<xref ref-type="fig" rid="fig4">Figure 4e</xref>). Notably, neither <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> nor <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females with day 8 LIF injection were able to support full-term pregnancy, in spite of implantation occurring 2 days after LIF injection in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> females (<xref ref-type="fig" rid="fig4">Figure 4e</xref>). These results suggest that uterine readiness for reactivation in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> deteriorates during diapause with preimplantation E<sub>2</sub> secretion.</p></sec><sec id="s2-5"><title>Progesterone supplement during diapause improves pregnancy outcomes in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females after reactivation</title><p>Progesterone is required to maintain uterine quiescence and blastocyst viability in mouse embryonic diapause. Embryonic diapause is also experimentally induced in the mouse by ovariectomy on day 4 of pregnancy before E<sub>2</sub> secretion and maintained by daily P<sub>4</sub> injections (<xref ref-type="bibr" rid="bib36">Yoshinaga and Adams, 1966</xref>; <xref ref-type="bibr" rid="bib23">Renfree and Fenelon, 2017</xref>). To examine if P<sub>4</sub> levels decrease without implantation in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females, we evaluated serum concentration of P<sub>4</sub> on days 4 and 8 of pregnancy and E<sub>2</sub> on day 4 pregnancy in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic>, <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup>,</italic> and <italic>Foxa2<sup>f/f</sup></italic> females. P<sub>4</sub> and E<sub>2</sub> levels in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females were comparable to those in <italic>Foxa2</italic><sup>f/f</sup> mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>).</p><p>Although <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females have normal P<sub>4</sub> and E<sub>2</sub> levels, the uterine edema in <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females 2 days after LIF injection on day 8 (<xref ref-type="fig" rid="fig4">Figure 4b</xref>) suggests increased estrogenic effects during diapause. Therefore, we administered P<sub>4</sub> on days 5, 7, and 9 with LIF injection on day 8 to counter the increased estrogenic effects in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). Embryo implantation was evaluated 2 days after LIF administration. All <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females had implantation sites with distinct blue bands (<xref ref-type="fig" rid="fig5">Figure 5b and d</xref>). Histological analysis identified embryos in the implantation chambers in mice of both genotypes (<xref ref-type="fig" rid="fig5">Figure 5c</xref>). Implantation rates and the numbers of implantation sites appear normal (<xref ref-type="fig" rid="fig5">Figure 5d</xref>). A comparable decidual response as revealed by <italic>Bmp2</italic> RNA levels is observed between these P<sub>4</sub> supplemented <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> females 2 days after LIF injection and <italic>Foxa2<sup>f/f</sup></italic> implantation sites on day 6 of natural pregnancy (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Furthermore, around 40% of <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females successfully delivered progeny, although litter sizes were small (2~3 pups/litter) (<xref ref-type="fig" rid="fig5">Figure 5e</xref>). These data suggest that P<sub>4</sub> supplementation improves uterine conditions during diapause in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> mice.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Counterbalance of estrogenic effects by P<sub>4</sub> improves maintenance of diapause in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> mice.</title><p>(<bold>a</bold>) Scheme of P<sub>4</sub> treatment. <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> mice were treated with leukemia inhibitory factor (LIF) (20 μg) on day 8. Pregnancy was evaluated on day 10, 2 days after LIF administration. (<bold>b</bold>) Representative photographs of uteri in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> mice with P<sub>4</sub> supplement 2 days after LIF administration. Scale bar: 10 mm. Histological pictures of implantation sites in panel b were presented in panel <bold>c</bold>. Scale bar: 500 μm. (<bold>d</bold>) Average number of implantation sites in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> mice with P<sub>4</sub> supplement. Numbers and percentage on bars indicate mice with implantation sites over total number of mated mice. (<bold>e</bold>) Litter sizes of <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>mice with P<sub>4</sub> supplement. Numbers and percentage on bars indicate mice with pups over total number of mated mice.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78277-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Serums levels of P<sub>4</sub> and E<sub>2</sub> in <italic>Foxa2<sup>f/f</sup></italic>, <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup>,</italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>females on days 4 and 8 of pregnancy.</title><p>Numbers of animals examined are presented on bars.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78277-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Fluorescence in situ hybridization of <italic>Bmp2</italic>.</title><p>Implantation sites of <italic>Foxa2<sup>f/f</sup></italic> females were collected on day 6 of pregnancy. Implantation sites of <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> females with different treatments were collected 2 days after leukemia inhibitory factor (LIF) injections. Scale bar: 500 μm. Le, luminal epithelia; Ge, glandular epithelia; S, stroma. Asterisks represent the locations of embryos.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78277-fig5-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Suppression of estrogen action during diapause improves pregnancy outcomes in Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup> and Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup> females after reactivation</title><p>In mice, preimplantation E<sub>2</sub> secretion on day 4 of pregnancy triggers a receptive phase followed by a uterine refractory phase on day 5 onward if implantation fails to occur. This refractory phase persists until P<sub>4</sub> treatment is withdrawn (<xref ref-type="bibr" rid="bib31">Wang et al., 2004</xref>). This activity suggests that E<sub>2</sub> has a biphasic effect on embryo implantation: a positive effect to induce uterine receptivity and a negative effect in changing the receptive uterus to a nonreceptive state. In <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females, although E<sub>2</sub>-induced LIF expression was abolished, FOXA2-independent negative estrogenic effects may gradually induce the refractory phase in uteri. To test this possibility, we administrated an ER antagonist (ICI-182780, named ICI) on days 3, 5, and 7 before day 8 LIF injection in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). Of note, embryonic diapause can also be experimentally induced in mice via 50 mg ICI injections on days 3 and 4 (<xref ref-type="bibr" rid="bib2">Cha et al., 2013</xref>). We have also confirmed this observation in our present study. To avoid the suppression of E<sub>2</sub>-induced LIF secretion on day 4, the dose of ICI was lowered to 25 mg per injection, the level at which implantation occurs normally in <italic>Foxa2<sup>f/f</sup></italic>females (<xref ref-type="fig" rid="fig6">Figure 6b</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Neutralization of estrogenic effects by ICI improves diapause in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> mice.</title><p>(<bold>a</bold>) Scheme of ICI treatment. <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> mice were treated with leukemia inhibitory factor (LIF) (20 μg) on day 8. Pregnancy was evaluated on day 10, 2 days after LIF administration. (<bold>b</bold>) Representative photographs of uteri in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> mice with ICI treatment 2 days after LIF administration. <italic>Foxa2<sup>f/f</sup></italic> mice have normal day 10 implantation sites, suggesting implantation occurs under 25 μg ICI treatment in <italic>Foxa2<sup>f/f</sup></italic> mice. Scale bar: 10 mm. Histological pictures of implantation sites in panel b were presented in panel <bold>c</bold>. Scale bar: 500 μm. (<bold>d</bold>) Average number of implantation sites in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic> mice with ICI treatment. Numbers and percentage on bars indicate mice with implantation sites over total number of mated mice. (<bold>e</bold>) Litter sizes of <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>mice with ICI treatment. Numbers and percentage on bars indicate mice with pups over total number of mated mice.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78277-fig6-v2.tif"/></fig><p>Similar to P<sub>4</sub> supplement, ICI treatment improved uterine responses to LIF-induced reactivation of embryos in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females. Implantation sites with distinct blue bands were observed in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females 2 days after LIF injection (<xref ref-type="fig" rid="fig6">Figure 6b</xref>). Embryos were identified in implantation chambers in both <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> mice (<xref ref-type="fig" rid="fig6">Figure 6c</xref>). Quantitatively, 55.5% of <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> females and 37.5% of <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females had implantation sites; the number of implantation sites in these mice is comparable to those in <italic>Foxa2<sup>f/f</sup></italic> females (<xref ref-type="fig" rid="fig6">Figure 6d</xref>). A comparable decidual response as indicated by <italic>Bmp2</italic> expression is observed between ICI-treated <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> females 2 days after LIF injection and <italic>Foxa2<sup>f/f</sup></italic> implantation sites on day 6 of natural pregnancy (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Surprisingly, 50% of <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> females supported pregnancy to full-term with a litter size comparable to those of <italic>Foxa2<sup>f/f</sup></italic> females (<xref ref-type="fig" rid="fig6">Figure 6e</xref>). However, no delivery was observed in <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females. These results suggest that a low level of ICI suppressed adverse estrogenic effects on uterine quiescence during diapause.</p><p>Diapause requires a favorable uterine environment to maintain dormant embryos. A putative idea of the E<sub>2</sub> secretion on day 4 mornings is to induce LIF and initiate the implantation process in a P<sub>4</sub>-primed mouse uterus. In the present studies, we have used mouse models conditionally deficient in <italic>Foxa2</italic>, and demonstrate that LIF suppression is not sufficient to maintain long-term uterine quiescence like in ovariectomized mice maintained on a P<sub>4</sub> supplement. Our study reveals that E<sub>2</sub> has an adverse impact on uterine quiescence independent of FOXA2/LIF (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>A representative scheme depicting roles of E<sub>2</sub>, FOXA2 (forkhead box protein A2), and leukemia inhibitory factor (LIF) in mouse diapause.</title><p>In natural pregnancy, a uterus enters a prereceptive phase before E<sub>2</sub> secretion in the morning of day 4. In the presence of FOXA2, LIF is induced by E<sub>2</sub> which renders the uterus into a receptive phase. In the event of implantation failure, the uterus becomes refractory on day 5 of pregnancy. The transition to the receptive phase is stopped if the E<sub>2</sub> secretion on day 4 is prevented by ovariectomy. The uterus remains quiescent as long as P<sub>4</sub> is supplemented; the embryonic development is arrested. A similar extension of prereceptive phase can be achieved by deleting FOXA2 or LIF. But the uterine quiescence is gradually compromised indicating that a LIF-independent estrogenic effect is detrimental to uterine quiescence.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78277-fig7-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Over 130 mammalian species experience diapause. The triggers for diapause across species vary widely including sucking stimuli, photoperiod, the availability of nutrition, and so forth (<xref ref-type="bibr" rid="bib9">Fenelon et al., 2014</xref>). The uterus is perhaps a determining factor for embryonic diapause in that a non-diapausing embryo undergoes dormancy in a diapausing uterus (<xref ref-type="bibr" rid="bib21">Ptak et al., 2012</xref>). During diapause, mammals temporarily arrest blastocyst development and metabolic activity within the uterus. In normal pregnancy, uterine sensitivity to implantation is classified into three phases in mice: prereceptive, receptive, and nonreceptive (refractory) (<xref ref-type="bibr" rid="bib32">Wang and Dey, 2006</xref>). Mouse uteri attain quiescence in diapause directly from the prereceptive phase via suppression of preimplantation E<sub>2</sub> secretion or LIF on day 4 of pregnancy (<xref ref-type="bibr" rid="bib36">Yoshinaga and Adams, 1966</xref>; <xref ref-type="bibr" rid="bib27">Stewart et al., 1992</xref>; <xref ref-type="bibr" rid="bib20">Paria et al., 1993b</xref>; <xref ref-type="bibr" rid="bib25">Song et al., 2000</xref>). However, the mechanism to induce embryonic diapause in mice is not clearly understood. In the current study, we show that depletion of uterine <italic>Foxa2</italic> triggers the mouse uterus to enter a quiescent status, which supports the arrest of embryonic development. A previous study showed that <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> females have implantation failure due to LIF suppression prior to implantation (<xref ref-type="bibr" rid="bib14">Kelleher et al., 2017</xref>), which potentially explains why <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> uteri are quiescent, since a single injection of LIF is sufficient to initiate embryo implantation. Dormant blastocysts were recovered from <italic>Lif<sup>-/-</sup></italic> females on day 7 of pregnancy (<xref ref-type="bibr" rid="bib27">Stewart et al., 1992</xref>).</p><p>Uterine depletion of <italic>Foxa2</italic> in either <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> or <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females is not sufficient to maintain complete uterine quiescence by suppressing all uterine metabolic activities. In diapause, quiescent uteri are readily reactivated by an injection of E<sub>2</sub> or LIF. However, our current study showed that only <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females with day 4 LIF injection delivered progeny; mice with day 8 LIF injection were unable to carry to term. Although <italic>Msx1</italic> persists in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> or <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uteri on day 8 of pregnancy, mice with day 8 LIF injections failed to continue pregnancy to full term, indicating the reactivation of the uteri had been compromised from day 4 to day 8. Compared with ovariectomy-induced diapause, <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females still have E<sub>2</sub> secretion on day 4 morning. Although E<sub>2</sub>-induced LIF expression is diminished, it is possible that E<sub>2</sub> continues to have some effects, independent of FOXA2 that slowly compromises uterine readiness for reactivation in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females. Furthermore, we show that detrimental estrogenic effects on diapause could be countered by P<sub>4</sub> supplement or ICI treatment.</p><p>The exact role of <italic>Foxa2</italic> in LIF induction by E<sub>2</sub> is not clearly understood. FOXA2 is a nuclear transcription factor and is involved in cell commitment, differentiation, and gene transcription in various organs including the lung, liver, pancreas, and gastrointestinal tract (<xref ref-type="bibr" rid="bib15">Lantz et al., 2004</xref>; <xref ref-type="bibr" rid="bib35">Wolfrum and Stoffel, 2006</xref>). Since both FOXA2 and ERs are transcription factors, it is possible that FOXA2 and ER synergistically turn on LIF activity. On the other hand, ER is activated by E<sub>2</sub> secretion in the morning of day 4, whereas <italic>Foxa2</italic> is constantly expressed in uterine glands, suggesting an alternative possibility that FOXA2 primes transcriptional regulatory regions of <italic>Lif</italic>, thus enabling ER binding. In fact, previous reports showed that FOXA2 is required for chromatin opening during endoderm differentiation (<xref ref-type="bibr" rid="bib1">Cernilogar et al., 2019</xref>) and for proper chromatin remodeling in human pancreas specification (<xref ref-type="bibr" rid="bib16">Lee, 2019</xref>).</p><p>Estrogen is harmful to uterine quiescence in mouse diapause. Estrogen is critical for the transition from the prereceptive to the receptive phase in P<sub>4</sub>-primed uteri (<xref ref-type="bibr" rid="bib32">Wang and Dey, 2006</xref>). Without implantation, mouse uteri enter the refractory phase after a short receptive phase (implantation window), suggesting that E<sub>2</sub> terminates the uterine receptive phase. There is evidence that E<sub>2</sub> concentration determines the duration of the uterine receptive phase, wherein a high dose of E<sub>2</sub> shortens the receptive period (<xref ref-type="bibr" rid="bib18">Ma et al., 2003</xref>). Conversely, mouse uteri in diapause are ready to be reactivated by a shot of E<sub>2</sub> as in the prereceptive phase. Ovariectomy-induced embryonic diapause could last for weeks in mice with continued P<sub>4</sub> treatment (<xref ref-type="bibr" rid="bib18">Ma et al., 2003</xref>; <xref ref-type="bibr" rid="bib34">Weitlauf and Greenwald, 1968</xref>), suggesting that uterine quiescence can be maintained for significant periods of time in the absence of E<sub>2</sub>. In <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females, LIF induction is suppressed, which avoids a quick switch to the refractory phase. However, the FOXA2-independent E<sub>2</sub> effect remains in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> uteri, slowly compromising the arrest of embryonic development and uterine quiescence. This dysfunction is further supported by our finding that P<sub>4</sub> or a low dose of ICI, which suppress E<sub>2</sub> function, improves the diapause condition in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females. These results indicate that estrogenic effects are not favorable to maintain diapause in mice.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals and treatment</title><p><italic>Foxa2<sup>f/f</sup></italic> mice on a CD1 background were generated as described (<xref ref-type="bibr" rid="bib29">Sund et al., 2000</xref>). This mouse line was originally obtained from Jeff Whitsett’s lab at our Institute. <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup></italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>mice were generated by mating <italic>Foxa2<sup>f/f</sup></italic> females with <italic>Ltf<sup>Cre</sup></italic><sup>/+</sup> males (C57BL/6 and albino B6 mixed background) and <italic>Pgr<sup>Cre</sup></italic><sup>/+</sup> mice. <italic>Ltf</italic><sup>Cre/+</sup> and <italic>Pgr<sup>Cre</sup></italic><sup>/+</sup> mice on a C57BL/6 background were generated as described (<xref ref-type="bibr" rid="bib7">Daikoku et al., 2014</xref>; <xref ref-type="bibr" rid="bib26">Soyal et al., 2005</xref>). <italic>Foxa2<sup>f/f</sup></italic>, <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup>,</italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>mice were housed in the animal care facility at Cincinnati Children’s Hospital Medical Center according to the National Institute of Health and institutional guidelines for laboratory animals. All protocols were approved by the Cincinnati Children’s Animal Care and Use Committee. Mice were provided with autoclaved Laboratory Rodent Diet 5010 (Purina) and UV light-sterilized reverse osmosis/deionized constant circulation water ad libitum. All mice used in this study were housed under a 12:12 hr light:dark cycle. At least three mice from each genotype were used for each individual experiment.</p></sec><sec id="s4-2"><title>Analysis of pregnancy events</title><p>Three adult (3 months of age) females from each genotype were randomly chosen and housed with a <italic>Foxa2<sup>f/f</sup></italic> fertile male overnight in separate cages; the morning of finding the presence of a vaginal plug was considered successful mating (day 1 of pregnancy), and these females are designated as mated females which were selected for pregnancy experiments. For analysis of parturition, parturition events were monitored from day 18 through day 27 by observing mice daily, morning, noon, and evening.</p><p>Litter size, pregnancy rate, gestation length, and outcomes were monitored. Implantation sites were examined on pregnancy day 6 or day 8. Blue reaction was performed by intravenous injection of a blue dye solution (Chicago Blue dye) 4 min before mice were sacrificed. Distinct blue bands along the uterus indicated implantation sites. For confirmation of pregnancy in mice showing no blue bands, one uterine horn was flushed with saline and checked for the presence of blastocysts. If blastocysts were present, the contralateral horn was used for experiments; mice without any blastocysts were excluded. ICI (Fulvestrant, Sigma-Aldrich, 25 μg/mouse/day) or progesterone (P<sub>4</sub>, Sigma-Aldrich, 2 mg/mouse/day) was administered in the morning (0900 hr). To induce implantation, a single injection of recombinant LIF (20 μg per mouse) was administrated in the morning (0900 hr). Embryo implantation sites were examined 2 days after LIF injection by intravenous injection of a blue dye solution.</p></sec><sec id="s4-3"><title>Histology</title><p>Tissue sections from control and experimental groups were processed on the same slide. Frozen sections (12 μm) were fixed in 4% paraformaldehyde (PFA) in PBS for 10 min at room temperature and then stained with hematoxylin and eosin (H&amp;E) for light microscopy analysis. Images presented are representative of three independent experiments.</p></sec><sec id="s4-4"><title>Immunostaining</title><p>Staining for FOXA2 (1:300, WRAB-FOXA2, Seven Hills Bioreagents), E-cadherin (1:300, 3195s, Cell Signaling Technology), EGFR (1:100, 4267, Cell Signaling Technology), Ki67 (1:200, MA5-14520, Invitrogen), and CK8 (1:100, TROMA-1, Hybridoma Bank, Iowa) was performed using secondary antibodies conjugated with Alexa 488 or Alexa 594 (1:300, Jackson Immuno Research). Nuclear staining was performed using Hoechst 33342 (4 µg/ml, H1399, Thermo Scientific). Tissue sections from control and experimental groups were processed on the same slide for each experiment. Images presented are representative of three independent experiments.</p></sec><sec id="s4-5"><title>Whole-mount immunostaining for 3D imaging</title><p>To reveal the tridimensional visualization of implantation sites, whole-mount immunostaining with 3DISCO clearing was performed as previously described (<xref ref-type="bibr" rid="bib37">Yuan et al., 2018</xref>). Anti-E-cadherin antibody (1:100, 3195s, Cell Signaling Technology) was used to stain the luminal epithelium. 3D images were acquired by a Nikon upright confocal microscope (Nikon A1R). To construct the 3D structure of the tissue, the surface tool in Imaris (Bitplane) was used.</p></sec><sec id="s4-6"><title>Fluorescence in situ hybridization</title><p>Digoxigenin (DIG)-labeled probes were generated according to the manufacturer’s protocol (Roche). PFA-fixed frozen sections from control and experimental groups were hybridized with DIG-labeled cRNA probes.Frozen sections (12 µm) from each genotype and treatment group were processed on the same slide for each probe. Briefly, following fixation (in 4% PFA/PBS) and acetylation, slides were hybridized at 55°C with DIG-labeled <italic>Lif</italic> and <italic>Msx1</italic> probe. Anti-DIG-peroxidase was applied onto hybridized slides following washing and peroxide quenching. Color was developed by TSA (Tyramide Signal Amplification) fluorescein according to the manufacturer’s instructions (PerkinElmer). Nuclear staining was performed using Hoechst 33342 (4 µg/ml, H1399, Thermo Scientific). Images presented are representative of three independent experiments.</p></sec><sec id="s4-7"><title>In situ hybridization using radioactive probes</title><p>In situ hybridization using radioactive (<sup>35</sup>S GTP) labeled <italic>Lif</italic> probes was performed as previously described (<xref ref-type="bibr" rid="bib30">Tan et al., 1999</xref>). In brief, frozen sections (12 μm) were mounted onto poly-L-lysine-coated slides and fixed in cold 4% PFA in PBS. The sections were prehybridized and hybridized at 45°C for 4 hr in 50% (vol/vol) formamide hybridization buffer containing <sup>35</sup>S-labeled anti-sense RNA probes (PerkinElmer). RNase A-resistant hybrids were detected by autoradiography. All sections were post-stained with H&amp;E. Images presented are representative of three independent experiments.</p></sec><sec id="s4-8"><title>Progesterone (P<sub>4</sub>) and estradiol-17b (E<sub>2</sub>) assays</title><p>Mouse blood samples were collected at 9:00 am on days 4 and 8 of pregnancy. Serum was separated by centrifugation and stored at –80°C until analysis. Serum hormonal levels in the serum were measured by P<sub>4</sub> or E<sub>2</sub> EIA kit (Cayman Chemical) as previously described (<xref ref-type="bibr" rid="bib6">Daikoku et al., 2011</xref>).</p></sec><sec id="s4-9"><title>Quantitative RT-PCR</title><p>RNAs from <italic>Foxa2<sup>f/f</sup></italic>, <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup>,</italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>mice uterine samples were analyzed as described previously (<xref ref-type="bibr" rid="bib28">Sun et al., 2014</xref>; <xref ref-type="bibr" rid="bib8">Das et al., 1995</xref>). In brief, total RNA was extracted with Trizol (Invitrogen, Waltham, MA) according to the manufacturer’s protocol. After DNase treatment (Ambion, Austin, TX), 1 µg of total RNA was reverse-transcribed with Superscript II (Invitrogen). Real-time PCR was performed using primers 5’-<named-content content-type="sequence">GACATACCGACGCAGCTACA</named-content>-3’ (sense) and 5’- <named-content content-type="sequence">GCCGGTAGAAAGGGAAGAGG</named-content>-3’ (anti-sense) for mouse <italic>Foxa2</italic>; 5’- <named-content content-type="sequence">GCAGATGTACCGCACTGAGATTC</named-content>-3’ (sense) and 5’-<named-content content-type="sequence">ACCTTTGGGCTTACTCCATTGATA</named-content>-3’ (anti-sense) for mouse <italic>Rpl7.</italic></p></sec><sec id="s4-10"><title>Statistical analysis</title><p>Each experiment was repeated at least three times using independent samples. Data are shown as mean ± SEM. Statistical analyses were performed using a two-tailed Student’s t-test. A value of p&lt;0.05 was considered statistically significant.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Validation, Visualization</p></fn><fn fn-type="con" id="con3"><p>Data curation, Validation, Visualization</p></fn><fn fn-type="con" id="con4"><p>Data curation, Validation</p></fn><fn fn-type="con" id="con5"><p>Resources, Data curation</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Formal analysis, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Formal analysis, Supervision, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Table 1.</title><p>Implantation sites in <italic>Foxa2<sup>f/f</sup></italic>, <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre+</sup>,</italic> and <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre+</sup></italic>females on day 8 of pregnancy.</p></caption><media xlink:href="elife-78277-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-78277-transrepform1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data are included in the manuscript.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Katie Gerhardt for her excellent editing of the manuscript. This work was supported in parts by NIH grants (HD103475 and HD068524 to SKD). YSK is supported by a National Research Foundation of Korea (NRF) grant (NRF-2021R1A6A3A03038446).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cernilogar</surname><given-names>FM</given-names></name><name><surname>Hasenöder</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Scheibner</surname><given-names>K</given-names></name><name><surname>Burtscher</surname><given-names>I</given-names></name><name><surname>Sterr</surname><given-names>M</given-names></name><name><surname>Smialowski</surname><given-names>P</given-names></name><name><surname>Groh</surname><given-names>S</given-names></name><name><surname>Evenroed</surname><given-names>IM</given-names></name><name><surname>Gilfillan</surname><given-names>GD</given-names></name><name><surname>Lickert</surname><given-names>H</given-names></name><name><surname>Schotta</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Pre-marked chromatin and transcription factor co-binding shape the pioneering activity of Foxa2</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>9069</fpage><lpage>9086</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz627</pub-id><pub-id pub-id-type="pmid">31350899</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Bartos</surname><given-names>A</given-names></name><name><surname>Fenelon</surname><given-names>J</given-names></name><name><surname>Lefèvre</surname><given-names>P</given-names></name><name><surname>Daikoku</surname><given-names>T</given-names></name><name><surname>Shaw</surname><given-names>G</given-names></name><name><surname>Maxson</surname><given-names>R</given-names></name><name><surname>Murphy</surname><given-names>BD</given-names></name><name><surname>Renfree</surname><given-names>MB</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A new role for muscle segment homeobox genes in mammalian embryonic diapause</article-title><source>Open Biology</source><volume>3</volume><elocation-id>130035</elocation-id><pub-id pub-id-type="doi">10.1098/rsob.130035</pub-id><pub-id pub-id-type="pmid">23615030</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>J</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cadence of procreation: orchestrating embryo-uterine interactions</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>34</volume><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2014.05.005</pub-id><pub-id pub-id-type="pmid">24862857</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>J</given-names></name><name><surname>Fenelon</surname><given-names>JC</given-names></name><name><surname>Murphy</surname><given-names>BD</given-names></name><name><surname>Shaw</surname><given-names>G</given-names></name><name><surname>Renfree</surname><given-names>MB</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A role for Msx genes in mammalian embryonic diapause</article-title><source>Bioscientifica Proceedings</source><volume>10</volume><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1530/biosciprocs.10.002</pub-id><pub-id pub-id-type="pmid">33215058</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JR</given-names></name><name><surname>Cheng</surname><given-names>JG</given-names></name><name><surname>Shatzer</surname><given-names>T</given-names></name><name><surname>Sewell</surname><given-names>L</given-names></name><name><surname>Hernandez</surname><given-names>L</given-names></name><name><surname>Stewart</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis</article-title><source>Endocrinology</source><volume>141</volume><fpage>4365</fpage><lpage>4372</lpage><pub-id pub-id-type="doi">10.1210/endo.141.12.7855</pub-id><pub-id pub-id-type="pmid">11108244</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daikoku</surname><given-names>T</given-names></name><name><surname>Cha</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Tranguch</surname><given-names>S</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Hirota</surname><given-names>Y</given-names></name><name><surname>Lydon</surname><given-names>J</given-names></name><name><surname>DeMayo</surname><given-names>F</given-names></name><name><surname>Maxson</surname><given-names>R</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Conditional deletion of Msx homeobox genes in the uterus inhibits blastocyst implantation by altering uterine receptivity</article-title><source>Developmental Cell</source><volume>21</volume><fpage>1014</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.09.010</pub-id><pub-id pub-id-type="pmid">22100262</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daikoku</surname><given-names>T</given-names></name><name><surname>Ogawa</surname><given-names>Y</given-names></name><name><surname>Terakawa</surname><given-names>J</given-names></name><name><surname>Ogawa</surname><given-names>A</given-names></name><name><surname>DeFalco</surname><given-names>T</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Lactoferrin-iCre: a new mouse line to study uterine epithelial gene function</article-title><source>Endocrinology</source><volume>155</volume><fpage>2718</fpage><lpage>2724</lpage><pub-id pub-id-type="doi">10.1210/en.2014-1265</pub-id><pub-id pub-id-type="pmid">24823394</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>SK</given-names></name><name><surname>Paria</surname><given-names>BC</given-names></name><name><surname>Chakraborty</surname><given-names>I</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Cannabinoid ligand-receptor signaling in the mouse uterus</article-title><source>PNAS</source><volume>92</volume><fpage>4332</fpage><lpage>4336</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.10.4332</pub-id><pub-id pub-id-type="pmid">7753807</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenelon</surname><given-names>JC</given-names></name><name><surname>Banerjee</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Embryonic diapause: development on hold</article-title><source>The International Journal of Developmental Biology</source><volume>58</volume><fpage>163</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1387/ijdb.140074bm</pub-id><pub-id pub-id-type="pmid">25023682</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenelon</surname><given-names>JC</given-names></name><name><surname>Renfree</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The history of the discovery of embryonic diapause in mammals</article-title><source>Biology of Reproduction</source><volume>99</volume><fpage>242</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1093/biolre/ioy112</pub-id><pub-id pub-id-type="pmid">29741586</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>CA</given-names></name><name><surname>Bartol</surname><given-names>FF</given-names></name><name><surname>Tarleton</surname><given-names>BJ</given-names></name><name><surname>Wiley</surname><given-names>AA</given-names></name><name><surname>Johnson</surname><given-names>GA</given-names></name><name><surname>Bazer</surname><given-names>FW</given-names></name><name><surname>Spencer</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Developmental biology of uterine glands</article-title><source>Biology of Reproduction</source><volume>65</volume><fpage>1311</fpage><lpage>1323</lpage><pub-id pub-id-type="doi">10.1095/biolreprod65.5.1311</pub-id><pub-id pub-id-type="pmid">11673245</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>JW</given-names></name><name><surname>Kwak</surname><given-names>I</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Large</surname><given-names>MJ</given-names></name><name><surname>Stewart</surname><given-names>CL</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Lydon</surname><given-names>JP</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Foxa2 is essential for mouse endometrial gland development and fertility</article-title><source>Biology of Reproduction</source><volume>83</volume><fpage>396</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1095/biolreprod.109.083154</pub-id><pub-id pub-id-type="pmid">20484741</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamemizu</surname><given-names>C</given-names></name><name><surname>Fujimori</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Distinct dormancy progression depending on embryonic regions during mouse embryonic diapause†</article-title><source>Biology of Reproduction</source><volume>100</volume><fpage>1204</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1093/biolre/ioz017</pub-id><pub-id pub-id-type="pmid">30715198</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelleher</surname><given-names>AM</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Pru</surname><given-names>JK</given-names></name><name><surname>Pru</surname><given-names>CA</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name><name><surname>Spencer</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Forkhead box a2 (FOXA2) is essential for uterine function and fertility</article-title><source>PNAS</source><volume>114</volume><fpage>E1018</fpage><lpage>E1026</lpage><pub-id pub-id-type="doi">10.1073/pnas.1618433114</pub-id><pub-id pub-id-type="pmid">28049832</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lantz</surname><given-names>KA</given-names></name><name><surname>Vatamaniuk</surname><given-names>MZ</given-names></name><name><surname>Brestelli</surname><given-names>JE</given-names></name><name><surname>Friedman</surname><given-names>JR</given-names></name><name><surname>Matschinsky</surname><given-names>FM</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Foxa2 regulates multiple pathways of insulin secretion</article-title><source>The Journal of Clinical Investigation</source><volume>114</volume><fpage>512</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1172/JCI21149</pub-id><pub-id pub-id-type="pmid">15314688</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>FOXA2 is required for enhancer priming during pancreatic differeIs Required for Enhancer Priming during Pancreatic Differentiation</article-title><source>Cell Reports</source><volume>28</volume><fpage>382</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.06.034</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>FL</given-names></name><name><surname>Desmarais</surname><given-names>JA</given-names></name><name><surname>Murphy</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Embryonic diapause and its regulation</article-title><source>Reproduction</source><volume>128</volume><fpage>669</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1530/rep.1.00444</pub-id><pub-id pub-id-type="pmid">15579584</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Das</surname><given-names>SK</given-names></name><name><surname>Paria</surname><given-names>BC</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation</article-title><source>PNAS</source><volume>100</volume><fpage>2963</fpage><lpage>2968</lpage><pub-id pub-id-type="doi">10.1073/pnas.0530162100</pub-id><pub-id pub-id-type="pmid">12601161</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paria</surname><given-names>BC</given-names></name><name><surname>Das</surname><given-names>SK</given-names></name><name><surname>Andrews</surname><given-names>GK</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="1993">1993a</year><article-title>Expression of the epidermal growth factor receptor gene is regulated in mouse blastocysts during delayed implantation</article-title><source>PNAS</source><volume>90</volume><fpage>55</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.1.55</pub-id><pub-id pub-id-type="pmid">7678348</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paria</surname><given-names>BC</given-names></name><name><surname>Huet-Hudson</surname><given-names>YM</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="1993">1993b</year><article-title>Blastocyst’s state of activity determines the “window” of implantation in the receptive mouse uterus</article-title><source>PNAS</source><volume>90</volume><fpage>10159</fpage><lpage>10162</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.21.10159</pub-id><pub-id pub-id-type="pmid">8234270</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ptak</surname><given-names>GE</given-names></name><name><surname>Tacconi</surname><given-names>E</given-names></name><name><surname>Czernik</surname><given-names>M</given-names></name><name><surname>Toschi</surname><given-names>P</given-names></name><name><surname>Modlinski</surname><given-names>JA</given-names></name><name><surname>Loi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Embryonic diapause is conserved across mammals</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e33027</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0033027</pub-id><pub-id pub-id-type="pmid">22427933</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renfree</surname><given-names>MB</given-names></name><name><surname>Shaw</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Diapause</article-title><source>Annual Review of Physiology</source><volume>62</volume><fpage>353</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1146/annurev.physiol.62.1.353</pub-id><pub-id pub-id-type="pmid">10845095</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renfree</surname><given-names>MB</given-names></name><name><surname>Fenelon</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The enigma of embryonic diapause</article-title><source>Development</source><volume>144</volume><fpage>3199</fpage><lpage>3210</lpage><pub-id pub-id-type="doi">10.1242/dev.148213</pub-id><pub-id pub-id-type="pmid">28928280</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>MI</given-names></name><name><surname>Barlow</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="1972">1972</year><article-title>Deoxyribonucleic acid content in delayed mouse blastocysts</article-title><source>Journal of Reproduction and Fertility</source><volume>29</volume><fpage>123</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1530/jrf.0.0290123</pub-id><pub-id pub-id-type="pmid">5016999</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Lim</surname><given-names>H</given-names></name><name><surname>Das</surname><given-names>SK</given-names></name><name><surname>Paria</surname><given-names>BC</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice</article-title><source>Molecular Endocrinology</source><volume>14</volume><fpage>1147</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1210/mend.14.8.0498</pub-id><pub-id pub-id-type="pmid">10935540</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soyal</surname><given-names>SM</given-names></name><name><surname>Mukherjee</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>KYS</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name><name><surname>Lydon</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cre-mediated recombination in cell lineages that express the progesterone receptor</article-title><source>Genesis</source><volume>41</volume><fpage>58</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1002/gene.20098</pub-id><pub-id pub-id-type="pmid">15682389</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>CL</given-names></name><name><surname>Kaspar</surname><given-names>P</given-names></name><name><surname>Brunet</surname><given-names>LJ</given-names></name><name><surname>Bhatt</surname><given-names>H</given-names></name><name><surname>Gadi</surname><given-names>I</given-names></name><name><surname>Köntgen</surname><given-names>F</given-names></name><name><surname>Abbondanzo</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor</article-title><source>Nature</source><volume>359</volume><fpage>76</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1038/359076a0</pub-id><pub-id pub-id-type="pmid">1522892</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Terakawa</surname><given-names>J</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>Daikoku</surname><given-names>T</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ovarian LGR5 is critical for successful pregnancy</article-title><source>FASEB Journal</source><volume>28</volume><fpage>2380</fpage><lpage>2389</lpage><pub-id pub-id-type="doi">10.1096/fj.13-248344</pub-id><pub-id pub-id-type="pmid">24469993</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sund</surname><given-names>NJ</given-names></name><name><surname>Ang</surname><given-names>SL</given-names></name><name><surname>Sackett</surname><given-names>SD</given-names></name><name><surname>Shen</surname><given-names>W</given-names></name><name><surname>Daigle</surname><given-names>N</given-names></name><name><surname>Magnuson</surname><given-names>MA</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Hepatocyte nuclear factor 3beta (Foxa2) is dispensable for maintaining the differentiated state of the adult hepatocyte</article-title><source>Molecular and Cellular Biology</source><volume>20</volume><fpage>5175</fpage><lpage>5183</lpage><pub-id pub-id-type="doi">10.1128/MCB.20.14.5175-5183.2000</pub-id><pub-id pub-id-type="pmid">10866673</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Paria</surname><given-names>BC</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name><name><surname>Das</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Differential uterine expression of estrogen and progesterone receptors correlates with uterine preparation for implantation and decidualization in the mouse</article-title><source>Endocrinology</source><volume>140</volume><fpage>5310</fpage><lpage>5321</lpage><pub-id pub-id-type="doi">10.1210/endo.140.11.7148</pub-id><pub-id pub-id-type="pmid">10537162</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Tejada</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Morrow</surname><given-names>JD</given-names></name><name><surname>Das</surname><given-names>SK</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Rescue of female infertility from the loss of cyclooxygenase-2 by compensatory up-regulation of cyclooxygenase-1 is a function of genetic makeup</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>10649</fpage><lpage>10658</lpage><pub-id pub-id-type="doi">10.1074/jbc.M312203200</pub-id><pub-id pub-id-type="pmid">14701858</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Roadmap to embryo implantation: clues from mouse models</article-title><source>Nature Reviews. Genetics</source><volume>7</volume><fpage>185</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1038/nrg1808</pub-id><pub-id pub-id-type="pmid">16485018</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>SP</given-names></name><name><surname>Brooks</surname><given-names>KE</given-names></name><name><surname>Kelleher</surname><given-names>AM</given-names></name><name><surname>Milano-Foster</surname><given-names>JJ</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name><name><surname>Spencer</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Generation of mouse for conditional expression of forkhead box A2</article-title><source>Endocrinology</source><volume>159</volume><fpage>1897</fpage><lpage>1909</lpage><pub-id pub-id-type="doi">10.1210/en.2018-00158</pub-id><pub-id pub-id-type="pmid">29546371</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weitlauf</surname><given-names>HM</given-names></name><name><surname>Greenwald</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="1968">1968</year><article-title>Survival of blastocysts in the uteri of ovariectomized mice</article-title><source>Journal of Reproduction and Fertility</source><volume>17</volume><fpage>515</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1530/jrf.0.0170515</pub-id><pub-id pub-id-type="pmid">5715681</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfrum</surname><given-names>C</given-names></name><name><surname>Stoffel</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion</article-title><source>Cell Metabolism</source><volume>3</volume><fpage>99</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2006.01.001</pub-id><pub-id pub-id-type="pmid">16459311</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshinaga</surname><given-names>K</given-names></name><name><surname>Adams</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="1966">1966</year><article-title>Delayed implantation in the spayed, progesterone treated adult mouse</article-title><source>Journal of Reproduction and Fertility</source><volume>12</volume><fpage>593</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1530/jrf.0.0120593</pub-id><pub-id pub-id-type="pmid">5928277</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>W</given-names></name><name><surname>Cha</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Borg</surname><given-names>JP</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Tridimensional visualization reveals direct communication between the embryo and glands critical for implantation</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>603</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03092-4</pub-id><pub-id pub-id-type="pmid">29426931</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78277.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Wei</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.03.15.484401" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.15.484401"/></front-stub><body><p>This manuscript reports the complex interactions that take place in the uterus between the endometrium and the blastocyst during and after embryonic diapause, a period of suspended animation that occurs in some mammals including the mouse, the model used here. The authors showed that one gene, Foxa2, interacts with two other genes, Msx1 and LIF, to control the success and duration of diapause. This will be of broad interest to researchers in the field of developmental biology and reproduction. It is a carefully done study, providing new information on the complex process that is diapause in which an embryo goes into suspended animation until it receives appropriate signaling from the uterine endometrial secretions to reactivate.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78277.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yan</surname><given-names>Wei</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Renfree</surname><given-names>Marilyn B</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ej9dk98</institution-id><institution>University of Melbourne</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.15.484401">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.03.15.484401v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>[Editors’ note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.]</p><p>Thank you for submitting the paper &quot;Targeted deletion of uterine glandular Foxa2 induces embryonic diapause in mice&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Marilyn B Renfree (Reviewer #2).</p><p>Comments to the Authors:</p><p>We are sorry to say that, after consultation with the reviewers, we have decided that this work will not be considered further for publication by <italic>eLife</italic>.</p><p>The manuscript is descriptive, and the findings are not particularly novel, given the known effects of Foxa2 depletion in the uterus, causing glandular defects. Foxa2 regulates LIF, and it is a well-known fact that Lif is essential for implantation. In addition, the model has not been adequately defined in terms of the depletion of the target genes. The demonstration that the embryos are in diapause is not convincing and recovered embryos should have been cultured or transplanted to demonstrate whether they are viable.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Molecular characterization of FOXA2 action needs to be carried out in addition to the interesting phenotype observed to make this manuscript more interesting to <italic>eLife</italic> readers.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>A set of private recommendations for the authors that outline how you think the science and its presentation could be strengthened.</p><p>This is such a complex set of interactions that would be made so much clearer if the authors would provide a line diagram summarising the key results and the relationship of each of the questions tested.</p><p>Also, they need to make it clear at what stage of pregnancy the Cre recombinase effects for the two mutant mice take place. It was confusing to understand the relationship between the various different stages of development (eg before puberty, in mature pregnant females, at day 4 of pregnancy, etc) examined to the timing of administration of the treatments. A table summarising these would help.</p><p>The assumption was made that &quot;plug-positive females' is instantly understood by everyone. Why not say mated females, or define it further in other ways.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1. Throughout, the Cre/lox effects should be referred to as depletion of Foxa2 rather than deletion or suppression.</p><p>2. Line 76: What does the quality of embryonic diapause mean?</p><p>3. Lines 110 et seq. The text indicates that implantation sites were rarely observed in either of the Cre/lox models, but then indicates that the frequency of mice with implantation sites was 16.7 and 42.9%. These do not seem to be rare occurrences. Supplemental Table 1 indicates that the number of implantation sites where present was within the normal range for mouse implantation in the depleted phenotypes.</p><p>4. Line 152: The concept of uterine readiness to be activated is vague and needs to be defined.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78277.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>[Editors’ note: The authors appealed the original decision. What follows is the authors’ response to the first round of review.]</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>Molecular characterization of FOXA2 action needs to be carried out in addition to the interesting phenotype observed to make this manuscript more interesting to eLife readers.</p></disp-quote><p>The current study addresses the question as to how the uterus enters into and maintains diapause. A study has shown that LIF is critical to implantation, and embryos in LIF KO mice enter diapause. However, our study shows this diapause in LIF KO lasts for a short period, whereas LIF independent estrogenic effects have adverse effects on embryonic diapause. Using mouse models deficient in Foxa2, we dissected out the LIF-dependent and -independent effects of estrogen secreted on day 4. The current study reveals previously unrealized roles of estrogen on uterine quiescence.</p><p>This reviewer’s interests regarding the exact role of Foxa2 in LIF induction is not within the scope of this study. However, this should not marginalize the importance of the present study. The interplay of transcription factors involving FoxA2, Msx1 and Esr1 in Lif induction and regulation of embryonic diapause will require further investigation for years.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>A set of private recommendations for the authors that outline how you think the science and its presentation could be strengthened.</p><p>This is such a complex set of interactions that would be made so much clearer if the authors would provide a line diagram summarising the key results and the relationship of each of the questions tested.</p><p>Also, they need to make it clear at what stage of pregnancy the Cre recombinase effects for the two mutant mice take place. It was confusing to understand the relationship between the various different stages of development (eg before puberty, in mature pregnant females, at day 4 of pregnancy, etc) examined to the timing of administration of the treatments. A table summarising these would help.</p><p>The assumption was made that &quot;plug-positive females' is instantly understood by everyone. Why not say mated females, or define it further in other ways.</p></disp-quote><p>We agree with these suggestions. We have now included a summarizing scheme (Figure 7). The timing of various treatments in different mouse models are shown in figures 4a, 5a and 6a.</p><p>All “plug-positive” are changed to “mated”.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>1. Throughout, the Cre/lox effects should be referred to as depletion of Foxa2 rather than deletion or suppression.</p></disp-quote><p>Manuscript has been revised accordingly.</p><disp-quote content-type="editor-comment"><p>2. Line 76: What does the quality of embryonic diapause mean?</p></disp-quote><p>We have revised the sentence in line 74. Notably, we found that balancing estrogenic effects by progesterone (P<sub>4</sub>) supplement or neutralization of estrogenic effects by an estrogen receptor antagonist significantly improves survival of embryos in <italic>Foxa2</italic> deficient mice.”</p><disp-quote content-type="editor-comment"><p>3. Lines 110 et seq. The text indicates that implantation sites were rarely observed in either of the Cre/lox models, but then indicates that the frequency of mice with implantation sites was 16.7 and 42.9%. These do not seem to be rare occurrences. Supplemental Table 1 indicates that the number of implantation sites where present was within the normal range for mouse implantation in the depleted phenotypes.</p></disp-quote><p>We revised the description in lines 110-112. In contrast, the numbers of implantation sites were significantly lower in <italic>Foxa2<sup>f/f</sup>Ltf<sup>Cre/+</sup></italic> or <italic>Foxa2<sup>f/f</sup>Pgr<sup>Cre/+</sup></italic> females as compared to <italic>Foxa2<sup>f/f</sup></italic> females (Figure 2a and Supplemental Table1).</p><disp-quote content-type="editor-comment"><p>4. Line 152: The concept of uterine readiness to be activated is vague and needs to be defined.</p></disp-quote><p>We revised this statement in line 155</p></body></sub-article></article>